Canagliflozin, a Sodium–glucose cotransporter-2 (SGLT2) inhibitor, attenuates pancreatic fibrosis in chronic pancreatitis through the AMPK–OPG–CTGF axis

Mendeley Data 2026 Dataset Open access

Read full text
Authors: Adachi, Akihisa
DOI: 10.17632/5x48kwxdjg
Cited by: 0

Abstract

Canagliflozin attenuates pancreatic fibrosis in chronic pancreatitis mediating through the AMPK–Canagliflozin, a Sodium–glucose cotransporter-2 (SGLT2) inhibitor, attenuates pancreatic fibrosis in chronic pancreatitis through the AMPK–OPG–CTGF axisOPG–CTGF axis

Publication details

Journal / source
Mendeley Data
Publication date
26 May 2026
Document type
Dataset